- Home
- RDAC vs IMRX Comparison
RDAC vs IMRX Comparison
Compare RDAC & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDAC
- IMRX
- Stock Information
- Founded
- RDAC 2024
- IMRX 2008
- Country
- RDAC China
- IMRX United States
- Employees
- RDAC N/A
- IMRX N/A
- Industry
- RDAC
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- RDAC
- IMRX Health Care
- Exchange
- RDAC NYSE
- IMRX Nasdaq
- Market Cap
- RDAC 75.2M
- IMRX 62.7M
- IPO Year
- RDAC 2024
- IMRX 2021
- Fundamental
- Price
- RDAC $10.05
- IMRX $2.02
- Analyst Decision
- RDAC
- IMRX Buy
- Analyst Count
- RDAC 0
- IMRX 7
- Target Price
- RDAC N/A
- IMRX $12.80
- AVG Volume (30 Days)
- RDAC 1.4K
- IMRX 4.9M
- Earning Date
- RDAC 01-01-0001
- IMRX 02-28-2025
- Dividend Yield
- RDAC N/A
- IMRX N/A
- EPS Growth
- RDAC N/A
- IMRX N/A
- EPS
- RDAC N/A
- IMRX N/A
- Revenue
- RDAC N/A
- IMRX N/A
- Revenue This Year
- RDAC N/A
- IMRX N/A
- Revenue Next Year
- RDAC N/A
- IMRX N/A
- P/E Ratio
- RDAC N/A
- IMRX N/A
- Revenue Growth
- RDAC N/A
- IMRX N/A
- 52 Week Low
- RDAC $10.19
- IMRX $1.00
- 52 Week High
- RDAC $10.31
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- RDAC N/A
- IMRX 47.82
- Support Level
- RDAC N/A
- IMRX $1.84
- Resistance Level
- RDAC N/A
- IMRX $3.80
- Average True Range (ATR)
- RDAC 0.00
- IMRX 0.29
- MACD
- RDAC 0.00
- IMRX -0.03
- Stochastic Oscillator
- RDAC 0.00
- IMRX 9.18
About RDAC RISING DRAGON ACQUISITION CORP
Rising Dragon Acquisition Corp is a blank check company.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.